Cargando…

The development and application of NRICM101 and NRICM102 for the treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Ho, Shung-Tai, Tsai, Yun-Ning, Su, Yi-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Formosan Medical Association. Published by Elsevier Taiwan LLC. 2023
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130323/ https://www.ncbi.nlm.nih.gov/pubmed/37147240 http://dx.doi.org/10.1016/j.jfma.2023.04.015

Ejemplares similares

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply
por: Lin, Sunny Jui-Shan, et al.
Publicado: (2022)

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3
por: Tseng, Yu-Hwei, et al.
Publicado: (2022)

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 2
por: Lee, Ming-Yung, et al.
Publicado: (2022)

Pharmacological Mechanism of NRICM101 for COVID-19 Treatments by Combined Network Pharmacology and Pharmacodynamics
por: Singh, Sher, et al.
Publicado: (2022)

Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101)
por: Su, Yi-Chang, et al.
Publicado: (2022)

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis
por: Wei, Wen-Chi, et al.
Publicado: (2022)

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
por: Tsai, Keng-Chang, et al.
Publicado: (2021)

In Silico and In Vitro studies of taiwan chingguan yihau (NRICM101) on TNF-α/IL-1β-induced human lung cells
por: Cheng, Yih-Dih, et al.
Publicado: (2022)

Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
por: Chang, Chun-Hao, et al.
Publicado: (2023)

ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury
por: Lin, Cheng-Han, et al.
Publicado: (2023)

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
por: Wei, Wen-Chi, et al.
Publicado: (2023)

Measurements of the beta-decay energy of $^{101}$Rb, $^{101,102}$Sr and $^{101,102}$Y
por: Balog, K, et al.
Publicado: (1990)

LPIC-1: (Exams 101 and 102)
por: Smith, Roderick W
Publicado: (2011)

Measurements on NM 102 and NM 101 with "Thorndahl" filter circuit
por: Fiebig, A
Publicado: (1980)

The decay of cadmium isotopes of mass 100, 101 and 102 isomers in silver
por: Hnatowich, D J, et al.
Publicado: (1970)

The decay of cadmium isotopes of mass 100, 101 and 102 to isomers in silver
por: Hnatowich, D J, et al.
Publicado: (1970)

101 years ago: Hermann Muller's remarkable insight
por: Haber, James E
Publicado: (2023)

Harnessing the power of synthetic data in healthcare: innovation, application, and privacy
por: Giuffrè, Mauro, et al.
Publicado: (2023)

CompTIA Linux+ Complete Study Guide (Exams LX0-101 and LX0-102)
por: Smith, Roderick W
Publicado: (2010)

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
por: Olaimat, Amin N., et al.
Publicado: (2020)

LPIC-1 : Linux Professional Institute Certification study guide : exam 101-500 and exam 102-500
por: Bresnahan, Christine, et al.
Publicado: (2019)

LPIC-1 Linux Professional Institute certification study guide: exam 101-400 and exam 102-400
por: Bresnahan, Christine, et al.
Publicado: (2015)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Learning from the past: development of safe and effective COVID-19 vaccines
por: Su, Shan, et al.
Publicado: (2020)

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
por: Zhang, Fen, et al.
Publicado: (2022)

Rapid response of a medical center upon the surge of COVID-19 epidemic in Taiwan
por: Huang, Jih-Hsin, et al.
Publicado: (2022)

The Potential Impact of COVID-19 on the Medical School Application
por: O’Connell, Rachel L, et al.
Publicado: (2020)

Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic
por: Turner, Leigh, et al.
Publicado: (2021)

WA102
por: Peters, K
Publicado: (1995)

Run 102
por: Schnell, Wolfgang
Publicado: (1971)

LPIC-1/CompTIA Linux+ certification exam guide (exams LPIC-1/LX0-101 & LX0-102)
por: Tracy, Robb H
Publicado: (2012)

102 Patient With COVID-19 Related Collapsing Glomerulopathy
Publicado: (2021)

Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics
por: Steinman, Jonathan Baruch, et al.
Publicado: (2020)

TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
por: Harford, Joe B., et al.
Publicado: (2022)

Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
por: Davis, Alysia, et al.
Publicado: (2022)

COVID-19 in Africa: Catalyzing change for sustainable development
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases
por: Zhu, Hong-Ming, et al.
Publicado: (2020)

Branch atheromatous disease and treatment
por: Duan, Honglian, et al.
Publicado: (2022)

Endoscopic treatment of hypertensive intracerebral hemorrhage: A technical review
por: Zhao, Yi-ning, et al.
Publicado: (2016)

Rectifying COVID-19 disparities with treatment and vaccination
por: Carethers, John M.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m7b3ivstisfqkv0jo87cudbqti